Medical Myths
with Dr Judy Mikovits
Ask Dr. Judy YOUR Questions Here; https://forms.gle/LQfQK7SqFFCpQcxp9
Show Description
Curious about true science? Are you tired of the censorship in regards to studies and research regarding Covid-19 and other “so called health threats” propagated by the MSM and the three letter agencies of the United States? This show is for you: Ask your questions the week prior and Dr. Judy will answer with data and facts. You deserve to know the truth. Know where to find it. Tune in and bring your critical questions. The essence of science is to ask the hard questions.
About Dr. Judy Mikovits
Dr Mikovits earned a BA in Chemistry from the University of Virginia in 1980 and a PhD in Biochemistry and Molecular Biology from George Washington University in 1992. In her forty-year quest to understand the causes, prevent and treat chronic diseases, she has co-authored seminal papers culminating at least a decade of research in each of four fields: immunology, natural products chemistry, epigenetics, and HIV/AIDs drug development.
In 2009 Dr Mikovits led the team that first isolated and characterized a new family of human disease-associated retroviruses, XMRVs/HGRVS. Dr Mikovits has co-authored more than 50 peer reviewed publications and book chapters; holds patent # WO 2012061790 A1. “Combination Therapy for Prostate Cancer using Botanical Compositions and Bicalutamide”.
Dr Mikovits is a New York Times Best selling author of the books, Plague Plague of Corruption and the Case Against the Masks and Ending Plague.
The formation of M.A.R.C. Inc. in 2016 with colleague, Dr. Frank Ruscetti, has afforded Dr. Mikovits the opportunity to come full-circle back to her first love, natural products chemistry. In 2020 MARC Inc evolved to become Dr J Solutions a company focused not only on education but on providing solutions for prevention and treatment autoimmune/auto-inflammatory diseases resulting from viral infection, drugs and environmental toxins. Her heart and passion is to focus on natural products chemistry and plant based drug therapies.
Her current focus is on medical cannabis with breakthroughs in understanding of the pathophysiology of neuroimmune diseases as acquired endocannabinoid immune dysfunction (AEIDS) including COVID19.
Episodes:
